From: Quantifying the impact of inhalational burns: a prospective study
Non-inhalational burns n (%) | Inhalational burns n (%) | p value | Adjusted OR* | 95% CI for OR | p value | |
---|---|---|---|---|---|---|
%TBSA > median,5 | 92 (55.1%) | 24 (68.6%) | 0.142 | 1.66 | 0.76–3.64 | 0.204 |
Age > median, 42 (years) | 88 (52.7%) | 14 (40.0%) | 0.172 | 0.71 | 0.31–1.62 | 0.414 |
Number of surgery sessions > median, 1 | 131 (78.4%) | 23 (65.7%) | 0.108 | 0.21 | 0.07–0.62 | 0.004 |
Length of stay > median, 8.5 (days) | 79 (47.3%) | 22 (62.9%) | 0.094 | 1.12 | 0.47–2.67 | 0.797 |
Days on IV antibiotics > median, 4 | 83 (49.7%) | 22 (62.9%) | 0.157 | 0.86 | 0.36–2.11 | 0.749 |
Days of mechanical ventilation > median, 2.5 | 3 (1.8%) | 15 (42.9%) | < 0.001 | 18.38 | 2.97–113.68 | 0.002 |
Initial P/F ratio < median, 394.02 | 3 (1.8%) | 14 (40.0%) | < 0.001 | 44.85 | 9.10–221.13 | < 0.001 |
Lowest P/F ratio < median, 343.88 | 1 (0.6%) | 15 (42.9%) | < 0.001 | 140.58 | 13.14–1504.25 | < 0.001 |
Lowest P/F ratio < 300 | 1 (0.6%) | 17 (48.6%) | < 0.001 | 480.70 | 28.47–8115.89 | < 0.001 |
Mortality | 1 (0.6%) | 6 (17.1%) P/F < 300:5/17(29.4%) P/F > 300:1/18 (5.6%) | < 0.001 | 0.604 | 0.01–44.53 | 0.818 |